Smith & Nephew plc

SNN NYSE SEC CIK 845982
Follow Smith & Nephew Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income12 fiscal years
  • Revenue
  • Net income
$0$2B$4B$6B$8BFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$6.2B$625M
FY24$5.8B$412M
FY23$5.5B$263M
FY22$5.2B$223M
FY21$5.2B$524M
FY20$4.6B$448M
FY19$5.1B$600M
FY18$4.9B$663M
FY17$4.8B$767M
FY16$4.7B$784M
FY15$4.6B$410M
FY14--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2568%12.9%10.1%
FY2469.6%11.3%7.1%
FY2368.8%7.7%4.7%
FY2270.5%8.6%4.3%
FY2170.4%11.4%10.1%
FY2069.4%6.5%9.8%
FY1974%15.9%11.7%
FY1873.5%17.6%13.5%
FY1773.8%19.6%16.1%
FY1672.8%17.2%16.8%
FY1575.3%13.6%8.8%
FY14---
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$250M$500M$750M$1BFY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$330M$502M
FY24$327M-
FY23$327M-
FY22$327M$158M
FY21$329M-
FY20$328M$16M
FY19$318M$63M
FY18$321M$48M
FY17$269M$52M
FY16$279M$368M
FY15$272M$77M
FY14--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Smith & Nephew
  • Healthcare median
−100%−75%−50%−25%0%25%FY15FY17FY19FY21FY23FY25
Show the numbers
YearSmith & NephewHealthcare median
FY2510.1%−30.6%
FY247.1%−47%
FY234.7%−58%
FY224.3%−80.4%
FY2110.1%−71.9%
FY209.8%−62.2%
FY1911.7%−46.3%
FY1813.5%−49.6%
FY1716.1%−45.9%
FY1616.8%−36%
FY158.8%−38.4%
FY14-−35.5%